Corticosteroids and rituximab as adjunctive treatments for thrombotic thrombocytopenic purpura

American Journal of Hematology

Volumn 87, Issue SUPPL. 1, 2012, Pages

  George, James N ^a,b  

^a UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^b UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DIPYRIDAMOLE; METHYLPREDNISOLONE; PREDNISONE; RECOMBINANT PROTEIN; RECOMBINANT VON WILLEBRAND FACTOR CLEAVING PROTEINASE; RITUXIMAB; UNCLASSIFIED DRUG; VINCRISTINE; VON WILLEBRAND FACTOR CLEAVING PROTEINASE;

ADJUVANT THERAPY; ANTICOAGULANT THERAPY; ARTICLE; AUTOIMMUNE DISEASE; CLINICAL EFFECTIVENESS; CORTICOSTEROID THERAPY; DISEASE EXACERBATION; DRUG EFFICACY; HEMOLYTIC UREMIC SYNDROME; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOMA; NOMENCLATURE; PLASMA TRANSFUSION; PLASMAPHERESIS; PRIORITY JOURNAL; PROGNOSIS; SPLENECTOMY; SURVIVAL RATE; SURVIVAL TIME; THROMBOTIC THROMBOCYTOPENIC PURPURA;

ADAM PROTEINS; ADRENAL CORTEX HORMONES; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; CATHETERIZATION, CENTRAL VENOUS; DISEASE-FREE SURVIVAL; HUMANS; IMMUNOLOGIC FACTORS; PLASMA EXCHANGE; PURPURA, THROMBOTIC THROMBOCYTOPENIC; RECOMBINANT PROTEINS; RECURRENCE; REMISSION INDUCTION; SURVIVAL RATE; VON WILLEBRAND FACTOR;

EID: 84859969602     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.23126     Document Type: Article

References (18)

1. Moschcowitz E. An acute febrile pleiochromic anemia with hyaline thrombosis of the terminal arterioles and capillaries. Arch Intern Med 1925; 36: 89-93.
2. Amorosi EL, Ultmann JE. Thrombotic thrombocytopenic purpura: Report of 16 cases and review of the literature. Medicine 1966; 45: 139-159.
3. Ridolfi RL, Bell WR. Thrombotic thrombocytopenic purpura. Report of 25 cases and review of the literature. Medicine 1981; 60: 413-428.
4. Rock GA, Shumak KH, Buskard NA, et al. Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. New Eng J Med 1991; 325: 393-397.
5. Rock GA, Shumak KH, Kelton JG et al. Thrombotic thrombocytopenic purpura: Outcome in 24 patients with renal impairment treated with plasma exchange. Transfusion 1992; 32: 710-714.
6. Kremer Hovinga JA, Vesely SK, Terrell DR, et al. Survival and relapse in patients with thrombotic thrombocytopenic purpura. Blood 2010; 115: 1500-1511.
7. George JN. How I treat patients with thrombotic thrombocytopenic purpura-2010. Blood 2010; 116: 4060-4069.
8. Bell WR, Braine HG, Ness PM, Kickler TS. Improved survival in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. New Eng J Med 1991; 325: 398-403.
9. George JN. How I treat patients with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Blood 2000; 96: 1223-1229.
10. Scully MF, McDonald V, Cavenagh JD, et al. A phase 2 study of the safety and efficacy of rituximab with plasma exchange in acute acquired thrombotic thrombocytopenic purpura. Blood 2011; 118: 1746-1753.
11. Nguyen L, Li X, Duvall D, et al. Efficacy of twice-daily plasma exchange for patients with refractory thrombotic thrombocytopenic purpura. Transfusion 2007; 48: 349-357.
12. Zaja F, Battista ML, Pirrotta MT, et al. Lower dose of rituximab is active in adult patients with idiopathic thrombocytopenic purpura. Haematologica 2008; 93: 930-933.
13. Cataland SR, Jin M, Zheng XL, et al. An evaluation of cyclosporine alone for the treatment of early recurrences of thrombotic thrombocytopenic purpura. J Thromb Haemost 2006; 4: 1162-1164.
14. Cataland SR, Jin M, Ferketich AK, et al. An evaluation of ciclosporine and corticosteroids individually as adjuncts to plasma exchange in the treatment of thrombotic thrombocytopenic purpura. Br J Haematol 2007; 132: 146-149.
15. Jin M, Casper C, Cataland SR, et al. Relationship between ADAMTS13 activity in clinical remission and the risk of TTP relapse. Br J Haematol 2008; 141: 651-658.
16. Cuttner J. Thrombotic thrombocytopenic purpura: A ten-year experience. Blood 1980; 56: 302-306.
17. Kremer Hovinga JA, Studt JD, Demarmels Biasiuttim F, et al. Splenectomy in relapsing and plasma-refractory acquired thrombotic thrombocytopenic purpura. Haematologica 2004; 89: 320-324.
18. Nguyen L, Terrell DR, Duvall D, et al. Complications of plasma exchange in patients treated for thrombotic thrombocytopenic purpura. IV. An additional study of 43 consecutive patients, 2005-2008. Transfusion 2009; 49: 392-394.